Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda
Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda operates in various business sectors.
Market Cap & Net Worth: Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda (RMDA)
Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda (EGX:RMDA) has a market capitalization of $832.14 (EGP42.07K) as of March 19, 2026. Listed on the EGX stock exchange, this Egypt-based company holds position #48389 globally and #174 in its home market, demonstrating a -0.46% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda's stock price EGP4.35 by its total outstanding shares 9672 (9.67K).
Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda Market Cap History: 2019 to 2026
Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda's market capitalization history from 2019 to 2026. Data shows change from $881.88 to $832.14 (-0.33% CAGR).
Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of RMDA by Market Capitalization
Companies near Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda in the global market cap rankings as of March 19, 2026.
Key companies related to Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda by market ranking:
- Ghandhara Tyre and Rubber Company Ltd (KAR:GTYR): Ranked #48380 globally with a market cap of $816.87 USD ( PKRs227.76K PKR).
- Marquie Group Inc (PINK:TMGI): Ranked #48381 globally with a market cap of $816.52 USD.
- Epazz Inc (PINK:EPAZ): Ranked #48390 globally with a market cap of $810.53 USD.
- Emperor Metals Inc. (OTCQB:EMAUF): Ranked #48391 globally with a market cap of $809.63 USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #48380 | Ghandhara Tyre and Rubber Company Ltd | KAR:GTYR | $816.87 | PKRs24.00 |
| #48381 | Marquie Group Inc | PINK:TMGI | $816.52 | $0.00 |
| #48390 | Epazz Inc | PINK:EPAZ | $810.53 | $0.04 |
| #48391 | Emperor Metals Inc. | OTCQB:EMAUF | $809.63 | $0.08 |
Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda Historical Marketcap From 2019 to 2026
Between 2019 and today, Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda's market cap moved from $881.88 to $ 832.14, with a yearly change of -0.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | EGP832.14 | +30.63% |
| 2025 | EGP637.02 | -0.30% |
| 2024 | EGP638.93 | +102.42% |
| 2023 | EGP315.64 | -44.44% |
| 2022 | EGP568.15 | +23.75% |
| 2021 | EGP459.11 | -37.01% |
| 2020 | EGP728.84 | -17.35% |
| 2019 | EGP881.88 | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $832.14 USD |
| MoneyControl | $832.14 USD |
| MarketWatch | $832.14 USD |
| marketcap.company | $832.14 USD |
| Reuters | $832.14 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.